Media
Company Description
With over 20 years of scientific innovations and discoveries, Ambry Genetics is a genetic testing industry leader enabling clinicians to better assess disease risk and make informed care decisions with their patients. As a company built by scientists, genetic counselors, and physicians, people remain at the center of each groundbreaking product and advancement.
Under the thoughtful and strategic leadership of Chief Executive Officer, Tom Schoenherr, Ambry Genetics works with some of the world's most respected academic institutions, top pharmaceutical companies, and leading treatment hospitals.
Leading new clinical product development pipelines and research collaborations, Chief Operating Officer, Dr. Brigette Tippin Davis, helps position Ambry Genetics at the forefront of clinical research and medicine. With a history of firsts in the field, Ambry continues to be a trusted source for pioneering solutions in clinical genetic testing aimed at helping us all strive toward better health.
CAP-accredited and CLIA-licensed, Ambry boasts the largest genetic sequencing lab in the world, and as part of REALM IDx, Inc., has access to the most complete suite of diagnostic technology.
Mission Statement
Ambry Genetics’ mission is to empower individuals with advanced genetic testing solutions that transform healthcare and promote the health of people worldwide.
Multimedia Assets
Executive Leadership
Ambry Headquarters
Logo
Download all multimedia assets in zip file
Frequently Asked Questions:
(Source: National Society of Genetic Counselors) https://nsgc.org/p/cm/ld/fid=43